Expected to kick off in 2018, the Fan-Controlled Football League (FCFL) reimagines American football – and the experience of being a die-hard fan – for the digital age. The FCFL will seek to deliver a compelling football product that captivates a broader digital audience. It will feature fast-paced, high-scoring action that embraces the spread-football evolution of the NCAA football and NFL games while enabling a diverse set of styles and strategies on both offense and defense ─ all controlled by the fans. Player personnel and real-time play calling decisions are all made by fans via the league’s blockchain platform, making fans the coach and general manager for their team. Fans will no longer be just viewers; rather, they will be active contributors to the games they are watching. This is a transformational shift in the way sports fans engage and interact: no more sitting back and passively watching as a team’s roster takes shape or a game unfolds. They will be essential to the league’s product both on the field and off. This is the democratization of sports, and it’s about to be realized through the most innovative sports league ever created, thanks to decentralized blockchain technology.

Take control of your personal data. Your data is used virtually every second you are online, to target you with ads. Data Choice will allow you to take control of what you share, what you keep private, control of the ads you see, and reward you for your data being used.

Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.

“You’ve got to start with the customer experience and work backwards to the technology. You can’t start with the technology and try to figure out where can I sell it.” -Steve Jobs UNIMOON is tokenizing on Polygon Matic. We are building a layer 1 solution building on substrate and auction for a Polkadot parachain. We will be the first interoperable decentralized social media network partnering with Storj for our decentralized cloud data storage needs. Enabling users to have full ownership and control of their personal information where it is displayed and how it is displayed utilizing blockchain technology for storage of key information. UNIMOON is bridging the gap between web2.0 to web3.0 solving the greatest issue of adoption for blockchain technology in the simplest way possible starting with the user experience.

Rewards.com is introducing a global marketplace that brings together over 100,000,000 products and 7,000 merchants, including restaurants, travel, entertainment and retail. This marketplace will allow customers to earn and redeem, what we call RWRD tokens, at any participating merchant or be traded on the exchanges. We believe this solution will transform loyalty by taking cryptocurrency mainstream, building a healthy and strong token economy and restoring true value to the consumer reward.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.